Long-Acting Beta Agonist Asthma Pharmacogenetic Loci Identified in Two Multi-Racial Asthma Clinical Trials

V. Ortega (Winston-Salem, NC, United States of America), M. Daya (Denver, CO, United States of America), E. Ampleford (Winston-Salem, NC, United States of America), G. Hawkins (Winston-Salem, NC, United States of America), W. Moore (Winston-Salem, NC, United States of America), S. Peters (Winston-Salem, NC, United States of America), K. Barnes (Denver, CO, United States of America), E. Bleecker (Tucson, AZ, United States of America), D. Meyers (Tucson, AZ, United States of America)

Source: Virtual Congress 2021 – Asthma clinical trials and real-life studies
Session: Asthma clinical trials and real-life studies
Session type: E-poster
Number: 886

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
V. Ortega (Winston-Salem, NC, United States of America), M. Daya (Denver, CO, United States of America), E. Ampleford (Winston-Salem, NC, United States of America), G. Hawkins (Winston-Salem, NC, United States of America), W. Moore (Winston-Salem, NC, United States of America), S. Peters (Winston-Salem, NC, United States of America), K. Barnes (Denver, CO, United States of America), E. Bleecker (Tucson, AZ, United States of America), D. Meyers (Tucson, AZ, United States of America). Long-Acting Beta Agonist Asthma Pharmacogenetic Loci Identified in Two Multi-Racial Asthma Clinical Trials. 886

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Update on CADSET (Chronic Airway Disease Early Stratification) Clinical Research Collaboration
Source: Virtual Congress 2020 – New tools for diagnosis of obstructive diseases
Year: 2020


Aerobic Exercise Improves Asthma Phenotype in a Model of Severe Asthma: Involvement of Kinins
Source: Virtual Congress 2021 – Environmental and lifestyle impacts on chronic lung disease
Year: 2021


Chronic Airway Diseases Early Stratification (CADSET): a new ERS Clinical Research Collaboration
Source: Eur Respir J, 53 (3) 1900217; 10.1183/13993003.00217-2019
Year: 2019



Co-Morbidities Are Serious Confounders of Asthma in Severe Asthma
Source: Research Seminar 2007 - Severe Asthma
Year: 2007


Real-world Omalizumab and Mepolizumab treated Difficult Asthma Phenotypes and their Clinical Outcomes
Source: Virtual Congress 2021 – Advances in asthma treatment: monoclonal antibodies
Year: 2021

Dupilumab Effect on Lung Function in Patients With Uncontrolled, Moderate-to-Severe Asthma With an Allergic Phenotype
Source: International Congress 2019 – Understanding, monitoring and targeting severe asthma
Year: 2019


Curcumin as an Add-on Therapy of Moderate Partially Controlled Asthma
Source: International Congress 2017 – Asthma: mechanisms and treatment
Year: 2017


Comprehensive Metabolic Profiling Reveals Metabolic Perturbances and Identifies Potential Biomarkers in Chronic Persistent Bronchial Asthma with Different Levels of Eosinophilia Percentage
Source: International Congress 2019 – Evaluation of basic science in airway diseases
Year: 2019


Late Breaking Abstract - TriOptimize VIII – Improvement of Lung Function with Extrafine Single Inhaler Triple Therapy – Analysis of Response Patterns by Prior Treatment from a Real-World Study.
Source: Virtual Congress 2020 – Pharmacological management of COPD
Year: 2020


Late Breaking Abstract - Standard-of-Care Asthma Controller Regimen Reduction with Benralizumab Treatment: ANDHI In Practice Study
Source: Virtual Congress 2021 – Severe asthma: evaluation using patient-reported outcome measures (PROMs) and biomarkers, comorbidities and treatments
Year: 2021


Does a Tailored Intervention to Promote Adherence in Patients with Chronic Lung Disease Affect Exacerbations?
Source: International Congress 2019 – Exacerbations of airway diseases
Year: 2019

NRG1 Fusion-Positive Lung Cancers: Clinicopathologic Profile and Treatment Outcomes from a Global Multicenter Registry
Source: International Congress 2019 – Biology of lung cancer
Year: 2019

High Intensity Resistance Training Improves Respiratory, Peripheral, Quality of Life and Emotional Response in Elderly with Parkinson Disease
Source: International Congress 2017 – Best abstracts in pulmonary rehabilitation in patients with chronic lung diseases
Year: 2017

Immune-Related Adverse Events Associated with Immune Checkpoint Blockade in Lung Cancer – A restrospective study.
Source: International Congress 2019 – Treatment of lung cancer
Year: 2019


Responses to Two Different High-Intensity Interval Exercise Training Protocols on Pulmonary Function and Respiratory Muscle Strength In Diabetes Mellitus
Source: Virtual Congress 2021 – Physical activity, exercise training and (tele)rehabilitation in respiratory patients
Year: 2021


Targeting PDE3 Abrogates the Hallmarks of Asthma in Asthma Models
Source: International Congress 2018 – Tests and trends in asthma
Year: 2018


Study to Evaluate Satisfaction with the Inhalation Device Used by Patients with Asthma or Chronic Obstructive Pulmonary Disease and the Association with Adherence and Disease Control
Source: Virtual Congress 2020 – Novel insights into nursing interventions for managing patients with asthma and COPD
Year: 2020




Comparison of Clinical Efficacy and Safety between ultraLABAs and ultraLAMAs in Patients with COPD: A Systemic Review with a Meta-Analysis of Randomized Controlled Trials
Source: International Congress 2018 – Integrating pharmacological and non-pharmacological management in COPD: are we there yet?
Year: 2018



Impact of Eosinophilia and Time on Lung Function Decline in Adult Asthma
Source: International Congress 2018 – Clinical determinants and biomarkers of COPD
Year: 2018